Pfizer and BioNTech said today the data from the trial of their vaccine in children ages five to 11 showed the vaccine is safe and generates a "robust" response. This data comes after Pfizer's push for the FDA to authorize booster shots failed last week. Both of these developments raise plenty of questions, so we want to answer them. Dr. Joseph Sellers, president of the Medical Society of the State of New York and Pediatrician at the Bassett Medical Group, joins None of the Above to answer your most pressing COVID-19 questions.